Zhang B - Search Results

1

Correction to: Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung Adenocarcinoma.

Li C, Zhang B, Guo J, Hu F, Nie W, Zheng X, Wang L, Lou Y, Shen Y, Han B, Zhang X. Li C, et al. Among authors: zhang b, zhang x. Target Oncol. 2019 Aug;14(4):491. doi: 10.1007/s11523-019-00659-z. Target Oncol. 2019. PMID: 31317306

2

Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma.

Li C, Zhang B, Guo J, Hu F, Nie W, Zheng X, Wang L, Lou Y, Shen Y, Han B, Zhang X. Li C, et al. Among authors: zhang b, zhang x. Target Oncol. 2019 Aug;14(4):423-431. doi: 10.1007/s11523-019-00649-1. Target Oncol. 2019. PMID: 31270661

3

Going Beyond Results of the PEMBRO-RT Trial.

Zhang B, Han B. Zhang B, et al. JAMA Oncol. 2020 Jan 1;6(1):161-162. doi: 10.1001/jamaoncol.2019.5031. JAMA Oncol. 2020. PMID: 31750867 No abstract available.

4

Tyrosine Kinase Inhibitor-Related Hepatotoxicity in Patients with Advanced Lung Adenocarcinoma: A Real-World Retrospective Study.

Qian J, Zhang X, Zhang B, Yan B, Wang L, Gu P, Wang W, Wang H, Han B. Qian J, et al. Among authors: zhang b, zhang x. Cancer Manag Res. 2020 May 11;12:3293-3299. doi: 10.2147/CMAR.S237968. eCollection 2020. Cancer Manag Res. 2020. PMID: 32494193 Free PMC article.

5

Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis.

Chen Y, Wang S, Zhang B, Zhao Y, Zhang L, Hu M, Zhang W, Han B. Chen Y, et al. Among authors: zhang l, zhang b, zhang w. Target Oncol. 2020 Jun;15(3):337-345. doi: 10.1007/s11523-020-00724-y. Target Oncol. 2020. PMID: 32495159

6

Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery.

Xiong A, Li C, Xu J, Yang X, Nie W, Zhong H, Chu T, Zhang W, Zhong R, Pan F, Shen Y, Lou Y, Zhang B, Han B, Zhang X. Xiong A, et al. Among authors: zhang b, zhang w, zhang x. Lung Cancer. 2021 Apr;154:124-130. doi: 10.1016/j.lungcan.2021.02.029. Epub 2021 Feb 24. Lung Cancer. 2021. PMID: 33657514

7

Immune-Related Adverse Events and Efficacy-The More It Hurts, the Better It Works?

Zhang B, Nie W, Han B. Zhang B, et al. JAMA Oncol. 2021 Jun 1;7(6):944-945. doi: 10.1001/jamaoncol.2021.0729. JAMA Oncol. 2021. PMID: 33914011 No abstract available.

8

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC.

Chen Y, Yang Z, Wang Y, Hu M, Zhang B, Zhang Y, Qian F, Zhang W, Han B. Chen Y, et al. Among authors: zhang b, zhang w, zhang y. Front Oncol. 2021 Apr 16;11:671228. doi: 10.3389/fonc.2021.671228. eCollection 2021. Front Oncol. 2021. PMID: 33937084 Free PMC article.

9

Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation.

Li C, Nie W, Guo J, Xiong A, Zhong H, Chu T, Zhong R, Xu J, Lu J, Zheng X, Zhang B, Shen Y, Pan F, Han B, Zhang X. Li C, et al. Among authors: zhang b, zhang x. Respir Res. 2021 May 11;22(1):145. doi: 10.1186/s12931-021-01741-9. Respir Res. 2021. PMID: 33975616 Free PMC article.

10

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations.

Yang Z, Chen Y, Wang Y, Wang S, Hu M, Zhang B, Han B. Yang Z, et al. Among authors: zhang b. Front Oncol. 2021 Aug 16;11:681429. doi: 10.3389/fonc.2021.681429. eCollection 2021. Front Oncol. 2021. PMID: 34485120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,002 results

Search Page

Filters